New product: Prevymis (letermovir) 240 mg film-coated tablets

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
17 January 2019

Abstract

Letermovir inhibits cytomegalovirus (CMV) DNA terminase complex which is needed for cleavage and packaging of viral progeny DNA. It is licensed for prophylaxis of CMV reactivation and disease in adult CMV-seropositive recipients of allogeneic haematopoietic stem cell transplant.